|
(P1747) |
Dapagliflozin reduces thrombin generation and atherosclerosis in LDLr-deficient mice |
| |
|
C. Kohlmorgen, K. Feldmann, M. Grandoch, J. W. Fischer (Düsseldorf) |
|
(P1748) |
LMP7 immunoproteasome subunit deficiency does not alter atherogenesis in LDL receptor-deficient mice |
| |
|
B. Hewing, A. Ludwig, M. Poetzsch, C. Dan, D. Lauer, A. Petry, A. Görlach, G. Baumann, V. Stangl, K. Stangl, N. Wilck (Berlin, München) |
|
(P1749) |
NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice |
| |
|
H. Langbein, C. Brunßen, A. Hofmann, P. Cimalla, M. Brux, S. R. Bornstein, A. Deussen, E. Koch, H. Morawietz (Dresden) |
|
(P1750) |
GLP-1 und seine Spaltprodukte zeigen eine anti-inflammatorische Wirkung in der Nieren von db/db Mäusen. |
| |
|
J. Möllmann, B. M. Klinkhammer, R. Stöhr, C. Lebherz, N. Marx, P. Boor, M. Lehrke (Aachen) |
|
(P1751) |
Suppression of Th-1 specific immune responses by Litomosoides sigmodontis antigen and its impact on murine atherosclerosis onset |
| |
|
C. Kühn, M. Tauchi, J. Ajendra, A. Hoerauf, C. Stumpf, S. Achenbach, M. Hübner, B. Dietel (Erlangen, Bonn) |
|
(P1752) |
Cholesterol biosynthesis and transport are determined by the soluble epoxide hydrolase in mice |
| |
|
N. Mangels, S. Zukunft, T. Frömel, A. Wettenmann, I. Fleming (Frankfurt am Main) |